KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Change in Cash (2017 - 2025)

Elanco Animal Health's Change in Cash history spans 9 years, with the latest figure at $40.0 million for Q4 2025.

  • For Q4 2025, Change in Cash rose 281.82% year-over-year to $40.0 million; the TTM value through Dec 2025 reached $77.0 million, down 33.62%, while the annual FY2025 figure was $77.0 million, 33.62% down from the prior year.
  • Change in Cash for Q4 2025 was $40.0 million at Elanco Animal Health, up from -$34.0 million in the prior quarter.
  • Across five years, Change in Cash topped out at $185.0 million in Q4 2021 and bottomed at -$296.0 million in Q1 2022.
  • The 5-year median for Change in Cash is $5.5 million (2021), against an average of $2.0 million.
  • The largest annual shift saw Change in Cash crashed 3388.89% in 2022 before it skyrocketed 3600.0% in 2024.
  • A 5-year view of Change in Cash shows it stood at $185.0 million in 2021, then tumbled by 162.16% to -$115.0 million in 2022, then skyrocketed by 85.22% to -$17.0 million in 2023, then fell by 29.41% to -$22.0 million in 2024, then skyrocketed by 281.82% to $40.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Change in Cash are $40.0 million (Q4 2025), -$34.0 million (Q3 2025), and $52.0 million (Q2 2025).